These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28603218)

  • 21. Blastemal cells of nephroblastomatosis complex share an onco-developmental antigen with embryonic kidney and Wilms' tumor. An immunohistochemical study on polysialic acid distribution.
    Roth J; Blaha I; Bitter-Suermann D; Heitz PU
    Am J Pathol; 1988 Dec; 133(3):596-608. PubMed ID: 2849302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
    Yun K; Fidler AE; Eccles MR; Reeve AE
    Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary renal neoplasms of the dog.
    Baskin GB; De Paoli A
    Vet Pathol; 1977 Nov; 14(6):591-605. PubMed ID: 201076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant embryonal nephroma in an aged dog.
    Sagartz JW; Ayers KM; Cashell IG; Robinson FR
    J Am Vet Med Assoc; 1972 Dec; 161(12):1658-60. PubMed ID: 4344915
    [No Abstract]   [Full Text] [Related]  

  • 25. Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor.
    Rong Y; Cheng L; Ning H; Zou J; Zhang Y; Xu F; Liu L; Chang Z; Fu XY
    Cancer Res; 2006 Aug; 66(16):8049-57. PubMed ID: 16912181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathology in Practice.
    Evans SJM; Schaffer PA; Sluiter K; Simonson A; Avery PR
    J Am Vet Med Assoc; 2020 Feb; 256(4):435-437. PubMed ID: 31999519
    [No Abstract]   [Full Text] [Related]  

  • 27. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S; Tomlinson G; Nisen P; Haber DA
    Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Berberine inhibits Wilms' tumor cell progression through upregulation of Wilms' tumor gene on the X chromosome.
    Liu Y; Liu S
    Mol Med Rep; 2013 Nov; 8(5):1537-41. PubMed ID: 24002362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of class I and II major histocompatibility complex antigens in Wilms' tumour and normal developing human kidney.
    Borthwick GM; Hughes L; Holmes CH; Davis SJ; Stirrat GM
    Br J Cancer; 1988 Dec; 58(6):753-61. PubMed ID: 2465017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephroblastoma with liver and lung metastases in an adult dog.
    Nakayama H; Hayashi T; Takahashi R; Fujiwara K
    Nihon Juigaku Zasshi; 1984 Dec; 46(6):897-900. PubMed ID: 6097732
    [No Abstract]   [Full Text] [Related]  

  • 31. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
    Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
    Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of WT1 protein in fetal kidneys and Wilms tumors.
    Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
    Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
    Hewitt SM; Saunders GF
    Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
    Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
    Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
    Haber DA; Buckler AJ
    New Biol; 1992 Feb; 4(2):97-106. PubMed ID: 1313285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cell tube block technique and an immunohistochemistry panel including Wilms tumor 1 to assist in diagnosing cavitary effusions in dogs and cats.
    Marcos R; Marrinhas C; Malhão F; Canadas A; Santos M; Caniatti M
    Vet Clin Pathol; 2019 Mar; 48(1):50-60. PubMed ID: 30865320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the WT1 gene in Wilms' tumour.
    Haber DA; Housman DE
    Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.